中国科学技术大学 weixianxinhaoganyingyuwujunxingyanzhengshiyanshi--Home--Paper Publications

Paper Publications

22、 Golgi apparatus: an emerging platform for innate immunity. Y Tao, Y Yang, R Zhou, T Gong,Trends in cell biology,2020,
21、 Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity. Yi Huang, Huanyu Wang, Yize Hao, Hualong Lin, Menghao Dong, Jin Ye, Lei Song, Yunzhi Wang, Qingqing Li, Benjie Shan, Yizhou Jiang, Hongqi Li, Zhiming Shao, Guido Kroemer, Huafeng Zhang, Li Bai, Tengchuan Jin, Chao Wang, Yuting Ma, Yongping Cai, Chen Ding, Suling Liu, Yueyin Pan, Wei Jiang, Rongbin Zhou,Nature Cell Biology,2020,
20、 DAMP-sensing receptors in sterile inflammation and inflammatory diseases. T Gong, L Liu, W Jiang, R Zhou,Nature Reviews Immunology,2020,
19、 ApoC3: an ‘alarmin’triggering sterile inflammation. T Gong, R Zhou,Nature Immunology,2020,
18、 Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling. L Liu, T Gong, W Tao, B Lin, C Li, X Zheng, S Zhu, W Jiang, R Zhou,Nature Immunolog,2019,
17、 The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases. H Jiang, T Gong, R Zhou,Advances in immunology,2019,
16、 Control of inflammasome activation by phosphorylation. T Gong, W Jiang, R Zhou,Trends in biochemical sciences,2018,
15、 GPCRs in NLRP3 inflammasome activation, regulation, and therapeutics. T Tang, T Gong, W Jiang, R Zhou,Trends in pharmacological sciences,2018,
14、 Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Hongbin He, Hua Jiang, Yun Chen, Jin Ye, Aoli Wang, Chao Wang, Qingsong Liu, Gaolin Liang, Xianming Deng, Wei Jiang, Rongbin Zhou,Nature communications,2018,
13、 Orchestration of NLRP3 inflammasome activation by ion fluxes. T Gong, Y Yang, T Jin, W Jiang, R Zhou,Trends in immunology,2018,
12、 Tranilast directly targets NLRP 3 to treat inflammasome‐driven diseases. Yi Huang, Hua Jiang, Yun Chen, Xiaqiong Wang, Yanqing Yang, Jinhui Tao, Xianming Deng, Gaolin Liang, Huafeng Zhang, Wei Jiang, Rongbin Zhou,EMBO molecular medicine,2018,
11、 Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders.Hua Jiang, Hongbin He, Yun Chen, Wei Huang, Jinbo Cheng, Jin Ye, Aoli Wang, Jinhui Tao, Chao Wang, Qingsong Liu, Tengchuan Jin, Wei Jiang, Xianming Deng, Rongbin Zhou,Journal of Experimental Medicine,2017,

total34 2/3

first previous next last Page

QR code